Qiu Xiaodi, Rong Xianfang, Yang Jin, Lu Yi
Eye Institute, Eye and Ear, Nose, and Throat Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China.
Key Laboratory of Myopia, Ministry of Health, Shanghai, 200031, People's Republic of China.
BMC Ophthalmol. 2019 Feb 4;19(1):42. doi: 10.1186/s12886-019-1056-7.
To compare the protective effects of the histone deacetylase inhibitors (HDACis) β-hydroxybutyrate (βOHB), trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA) and valproic acid (VPA) on human lens epithelial cells(HLECs) following ultraviolet-B (UVB) exposure.
HLECs were divided into subgroups: four HDACi groups, a control group, a UVB-treated group and a DMSO group (cells treated with DMSO and UVB irradiation). In the HDACi groups, HLECs were cultured with different concentrations of HDACis 12 h prior to UVB irradiation. The protective effects of the HDACis were evaluated by assessing apoptosis rates, cell activity and expression levels of genes associated with apotosis (caspase-3, Bcl-2, BAX, SOD1, FOXO3A and MT2). The levels of superoxide dismutase (SOD), reactive oxygen species (ROS), malondialdehyde (MDA) and total antioxidant capacity (T-AOC) were detected in order to evaluate oxidative stress.
The results showed that SAHA (1 μmol/L, 2 μmol/L) and TSA (0.2 μmol/L) had mild protective effects on cell viability. βOHB (4 mmol/L) and TSA (0.2 mol/L) demonstrated protective effects on BCL-2 expression. TSA (0.2 mol/L) showed protective effects on SOD1 expression. TSA (0.2 mol/L) and SAHA (1 μmol/L) suppressed BAX and caspase-3 expression. TSA (0.2 mol/L, 0.8 mol/L) and SAHA (1 μmol/L, 2 μmol/L) suppressed the expression of FOXO3A and MT2. SOD levels were increased after treatment with βOHB (4 mmol/L), SAHA (8 μmol/L) and TSA (0.1 mol/L, 0.2 mol/L). T-AOC levels were increased in UVB-treated HLECs after treatment with SAHA (2 μmol/L). MDA levels decreased in UVB-treated HLECs following treatment with TSA (0.2 mol/L, 0.8 mol/L). ROS levels decreased in UVB-treated HLECs following treatment with βOHB (4 mmol/L), SAHA (1 μmol/L, 2 μmol/L) and TSA (0.2 mol/L). Western blotting results demonstrated that SOD1 levels significantly increased in the βOHB (4 mmol/L), SAHA (1 μmol/L, 2 μmol/L), TSA (0.1 mol/L, 0.2 mol/L) and VPA (5 mmol/L) groups. Only SAHA (1 μmol/L) had an anti-apoptotic effect on UVB-treated HLECs.
Our findings indicate that low concentrations of HDACis (1 μmol/L of SAHA) mildly inhibit oxidative stress, thus protecting HLECs from oxidation. These results may suggest that there is a possibility to explore the clinical applications of HDACis for treatment and prevention of cataracts.
比较组蛋白去乙酰化酶抑制剂(HDACis)β-羟基丁酸(βOHB)、曲古抑菌素A(TSA)、辛二酰苯胺异羟肟酸(SAHA)和丙戊酸(VPA)对紫外线B(UVB)照射后人晶状体上皮细胞(HLECs)的保护作用。
将HLECs分为亚组:四个HDACi组、一个对照组、一个UVB处理组和一个二甲基亚砜(DMSO)组(用DMSO处理并接受UVB照射的细胞)。在HDACi组中,HLECs在UVB照射前12小时用不同浓度的HDACis培养。通过评估凋亡率、细胞活性以及与凋亡相关基因(半胱天冬酶-3、Bcl-2、BAX、超氧化物歧化酶1(SOD1)、叉头转录因子O3A(FOXO3A)和金属硫蛋白2(MT2))的表达水平来评估HDACis的保护作用。检测超氧化物歧化酶(SOD)、活性氧(ROS)、丙二醛(MDA)和总抗氧化能力(T-AOC)水平以评估氧化应激。
结果表明,SAHA(1μmol/L、2μmol/L)和TSA(0.2μmol/L)对细胞活力有轻度保护作用。βOHB(4mmol/L)和TSA(0.2μmol/L)对BCL-2表达有保护作用。TSA(0.2μmol/L)对SOD1表达有保护作用。TSA(0.2μmol/L)和SAHA(1μmol/L)抑制BAX和半胱天冬酶-3表达。TSA(0.2μmol/L、0.8μmol/L)和SAHA(1μmol/L、2μmol/L)抑制FOXO3A和MT2表达。用βOHB(4mmol/L)、SAHA(8μmol/L)和TSA(0.1μmol/L、0.2μmol/L)处理后SOD水平升高。用SAHA(2μmol/L)处理后,UVB处理的HLECs中T-AOC水平升高。用TSA(0.2μmol/L、0.8μmol/L)处理后,UVB处理的HLECs中MDA水平降低。用βOHB(4mmol/L)、SAHA(1μmol/L、2μmol/L)和TSA(0.2μmol/L)处理后UVB处理的HLECs中ROS水平降低。蛋白质免疫印迹结果表明,βOHB(4mmol/L)、SAHA(1μmol/L、2μmol/L)、TSA(0.1μmol/L、0.2μmol/L)和VPA(5mmol/L)组中SOD1水平显著升高。只有SAHA(1μmol/L)对UVB处理的HLECs有抗凋亡作用。
我们的研究结果表明,低浓度的HDACis(1μmol/L的SAHA)可轻度抑制氧化应激,从而保护HLECs免受氧化损伤。这些结果可能提示探索HDACis在白内障治疗和预防中的临床应用具有可能性。